Skip to menu Skip to content Skip to footer
Dr

Qi Ruan

Email: 

Overview

Availability

Dr Qi Ruan is:
Available for supervision

Qualifications

  • Bachelor (Honours) of Biomedical Science, The University of Queensland
  • Doctor of Philosophy of Biomedical Science, The University of Queensland

Works

Search Professor Qi Ruan’s works on UQ eSpace

4 works between 2023 and 2025

1 - 4 of 4 works

2025

Journal Article

An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer

Ruan, Qi, Chen, Tao, Kim, Minwoo, Yang, Haotian, Sinha, Debottam, He, Yaowu, Burke, Lez, Wickramasuriya, Lashith, Cao, Lu, Yan, Weikang, Hooper, John, Wang, Haolu, Bridle, Kim, Chandra, Janin, Crawford, Darrell and Liang, Xiaowen (2025). An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer. Hepatology PMID 8302946. doi: 10.1097/hep.0000000000001639

An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer

2025

Conference Publication

Selective inhibition of PI3Kp110a enhances chemotherapy efficacy by suppressing hepatic stellate cell activation in liver cancer

Liang, X., Ruan, Q., Kim, M., Yang, H., Bridle, K. and Crawford, D. (2025). Selective inhibition of PI3Kp110a enhances chemotherapy efficacy by suppressing hepatic stellate cell activation in liver cancer. Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Berlin, Germany, 17 - 21 October 2025. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/j.annonc.2025.10.194

Selective inhibition of PI3Kp110a enhances chemotherapy efficacy by suppressing hepatic stellate cell activation in liver cancer

2024

Conference Publication

Chemotherapeutic drugs induce hepatic stellate cell activation in hepatocellular carcinoma via ROS-dependent PI3K pathway

Ruan, Qi, Cao, Lu, Yang, Haotian, Burke, Leslie, Bridle, Kim, Crawford, Darrell and Liang, Xiaowen (2024). Chemotherapeutic drugs induce hepatic stellate cell activation in hepatocellular carcinoma via ROS-dependent PI3K pathway. The Liver Meeting, San Diego, CA, United States, 15 - 19 November 2024. Philadelphia, PA, United States: Wolters Kluwer Health.

Chemotherapeutic drugs induce hepatic stellate cell activation in hepatocellular carcinoma via ROS-dependent PI3K pathway

2023

Conference Publication

Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancer

Ruan, Qi, Cao, Lu, Yang, Haotian, Burke, Leslie, Bridle, Kim, Crawford, Darrell and Liang, Xiaowen (2023). Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancer. EASL Congress 2023, Vienna, Austria, 21 - 24 June 2023. Amsterdam, Netherlands: Elsevier.

Reactive oxygen species-mediated hepatic stellate cell activation via PI3K in liver cancer

Supervision

Availability

Dr Qi Ruan is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Dr Qi Ruan's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au